Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Kuittinen, O. (Outi)"'
Autor:
Kuittinen, O. (Outi)
Gelatinases (MMP-2 and MMP-9) play a key role during invasion and metastazising of malignant cells and they have been shown to be associated to invasive phenotype and poor prognosis in several solid tumours. However little is known about their role i
Externí odkaz:
http://urn.fi/urn:isbn:951426942X
Autor:
Poltojainen, V. (Valter), Kemppainen, J. (Janette), Keinänen, N. (Nina), Bode, M. (Michaela), Isokangas, J.-M. (Juha-Matti), Kuitunen, H. (Hanne), Nikkinen, J. (Juha), Sonkajärvi, E. (Eila), Korhonen, V. (Vesa), Tuovinen, T. (Timo), Järvelä, M. (Matti), Huotari, N. (Niko), Raitamaa, L. (Lauri), Kananen, J. (Janne), Korhonen, T. (Tommi), Tetri, S. (Sami), Kuittinen, O. (Outi), Kiviniemi, V. (Vesa)
Primary central nervous system lymphoma (PCNSL) is an aggressive brain disease where lymphocytes invade along perivascular spaces of arteries and veins. The invasion markedly changes (peri)vascular structures but its effect on physiological brain pul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2423::d1c1746bcb8f3dbdfb13828649d91ade
http://urn.fi/urn:nbn:fi-fe2023062759498
http://urn.fi/urn:nbn:fi-fe2023062759498
Autor:
Chan, M. C. (Mikko C.), Savela, J. (Janette), Ollikainen, R. K. (Riina K.), Teppo, H.-R. (Hanna-Riikka), Miinalainen, I. (Ilkka), Pirinen, R. (Risto), Kari, E. J. (Esa J. M.), Kuitunen, H. (Hanne), Turpeenniemi-Hujanen, T. (Taina), Kuittinen, O. (Outi), Kuusisto, M. E. (Milla E. L.)
DLBCL is the most common type of non-Hodgkin lymphoma with a substantial group of patients suffering a poor prognosis. Therefore more specific markers are required for better understanding of disease biology and treatment. This study demonstrates tha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2423::f46fa63eb7fec776e178f8b7eb0b92b2
http://urn.fi/urn:nbn:fi-fe2021041610781
http://urn.fi/urn:nbn:fi-fe2021041610781
Autor:
Ollikainen, R. K. (Riina K.), Kotkaranta, P. H. (Pyry H.), Kemppainen, J. (Janette), Teppo, H.-R. (Hanna-Riikka), Kuitunen, H. (Hanne), Pirinen, R. (Risto), Turpeenniemi-Hujanen, T. (Taina), Kuittinen, O. (Outi), Kuusisto, M. E. (Milla E.L.)
Although treatment for diffuse large B-cell lymphoma (DLBCL) has taken some notable steps in the 2000s, there are still subgroups of patients suffering from high mortality and relapse rates. To further improve treatment outcomes, it is essential to d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2423::821ba648a87b1d15122bcf576ead9dcc
http://urn.fi/urn:nbn:fi-fe2021122162825
http://urn.fi/urn:nbn:fi-fe2021122162825
Autor:
Tokola, S. (Susanna), Kuitunen, H. (Hanne), Turpeenniemi-Hujanen, T. (Taina), Kuittinen, O. (Outi)
The application of positron emission tomography (PET)-computed tomography (CT) in treatment response evaluation has increased in diffuse large B-cell lymphoma (DLBCL), although its predictive value is controversial. We retrospectively analyzed the ra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2423::ac9ef11a9a9c7ea190bb4e083d952ac5
http://urn.fi/urn:nbn:fi-fe2021061436816
http://urn.fi/urn:nbn:fi-fe2021061436816
Autor:
Kiiskilä, J. (Jenni), Uotila, P. (Pyry), Haapasaari, K.-M. (Kirsi-Maria), Kauppila, S. (Saila), Teppo, H.-R. (Hanna-Riikka), Kuusisto, M. E. (Milla E. L.), Lemma, S. (Siria), Turpeenniemi-Hujanen, T. (Taina), Vornanen, M. (Martine), Eray, M. (Mine), Kuittinen, O. (Outi)
Summary Follicular T-cell lymphoma (FTCL) is a rare subtype of mature T-cell lymphoma. It was recently recognized as a separate lymphoma entity in the 2017 revised fourth edition of the World Health Organization classification. The main goals of the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2423::a427f044181129c85786fe461f594444
http://urn.fi/urn:nbn:fi-fe2021122162718
http://urn.fi/urn:nbn:fi-fe2021122162718
Autor:
Tokola, S. (Susanna), Kuitunen, H. (Hanne), Turpeenniemi-Hujanen, T. (Taina), Kuittinen, O. (Outi)
Bulky and residual tumor are considered to increase the risk of relapse in diffuse large B‐cell lymphoma (DLBCL) patients. Radiotherapy is conventionally used to reduce the risk, but the evidence is controversial. We performed a retrospective analy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2423::617f51cddb480cdf5f683f1880b6a944
http://urn.fi/urn:nbn:fi-fe2020042822874
http://urn.fi/urn:nbn:fi-fe2020042822874
Autor:
Turunen, A. (Antti), Partanen, A. (Anu), Valtola, J. (Jaakko), Ropponen, A. (Antti), Siitonen, T. (Timo), Kuittinen, O. (Outi), Kuitunen, H. (Hanne), Putkonen, M. (Mervi), Sankelo, M. (Marja), Keskinen, L. (Leena), Savolainen, E. (Eeva‐Riitta), Pyörälä, M. (Marja), Kuittinen, T. (Taru), Silvennoinen, R. (Raija), Penttilä, K. (Karri), Sikiö, A. (Anu), Vasala, K. (Kaija), Mäntymaa, P. (Pentti), Pelkonen, J. (Jukka), Varmavuo, V. (Ville), Jantunen, E. (Esa)
Background: Autologous stem cell transplantation is an established treatment option for patients with multiple myeloma (MM) or non‐Hodgkinʼs lymphoma (NHL). Study design and methods: In this prospective multicenter study, 147 patients with MM were
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2423::2ce12e81de33350b9d630814a00c0d82
http://urn.fi/urn:nbn:fi-fe2020091769957
http://urn.fi/urn:nbn:fi-fe2020091769957
Autor:
Uotila, P. M. (Pyry M.), Lemma, S. A. (Siria A.), Haapasaari, K.-M. (Kirsi-Maria), Porvari, K. (Katja), Skarp, S. (Sini), Soini, Y. (Ylermi), Jantunen, E. (Esa), Turpeenniemi-Hujanen, T. (Taina), Kuittinen, O. (Outi)
Objectives: To investigate the protein expression of the epithelial-mesenchymal transition-inducing transcription factors (TFs) Twist, ZEB1 and Slug in peripheral T-cell lymphomas (PTCL) and their correlation with clinical parameters. Methods: The ex
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2423::e177f5a60014f5012208eb96d453e88f
http://urn.fi/urn:nbn:fi-fe2020090267261
http://urn.fi/urn:nbn:fi-fe2020090267261
Autor:
Kari, E. (Esa), Kuusisto, M. (Milla), Honkavaara, P. (Päivi), Hakalahti, A. (Anna), Haapasaari, K. (Kirsi‐Maria), Bloigu, R. (Risto), Karihtala, P. (Peeter), Teppo, H. (Hanna‐Riikka), Pirinen, R. (Risto), Turpeenniemi‐Hujanen, T. (Taina), Kuittinen, O. (Outi)
Objective: In diffuse large B‐cell lymphoma (DLBCL), there is an unmet medical need to select patients who would benefit from intensified frontline treatments such as adding etoposide to an R‐CHOP regimen. Methods: The present work included a ret
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2423::9a975856deec6930c1b65d82ead670cf
http://urn.fi/urn:nbn:fi-fe2020091469412
http://urn.fi/urn:nbn:fi-fe2020091469412